Previous meta-analyses of 5HT3 antagonists have reported on the efficacy of ondansetron as an adjunctive treatment for negative symptoms and general psychopathology in patients with chronic, stable schizophrenia [21]. This evidence concerns the gene HTR3A and schizophrenia.